血sCD146是慢性阻塞性肺病急性恶化的潜在生物标志物
Xinyu Jia1, Jingxian Jiang1, Chen Yang2
1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Clinical and translational science
|March 13, 2024
概括
在经历慢性阻塞性肺病 (COPD) 急性恶化患者中,可溶性CD146 (sCD146) 水平较低. 下SCD146与疾病严重程度的增加有关,并作为COPD恶化的一个独立风险因素.
科学领域:
- 肺部医学 肺部医学
- 生物标志物 生物标志物
- 免疫学 免疫学 免疫学
背景情况:
- 慢性阻塞性肺病 (COPD) 是一个重大的全球健康挑战.
- 确定COPD恶化的可靠生物标志物对于及时干预至关重要.
- 溶性CD146 (sCD146) 是一种细胞粘附分子,在炎症性疾病中具有潜在的作用.
研究的目的:
- 为了研究COPD患者的血sCD146水平.
- 评估sCD146水平与COPD严重程度之间的相关性.
- 确定sCD146是否可以作为COPD急性恶化 (AECOPD) 的生物标志物.
主要方法:
- 从97名COPD患者 (13名稳定,84名恶化) 收集了血样本.
- 测量了sCD146水平,并在稳定和恶化的组之间进行了比较.
- 分析了与COPD严重性指数 (mMRC,GOLD阶段,CAT得分,住院病例) 的相关性.
- 进行了后勤回归和ROC分析,以评估sCD146作为AECOPD的生物标志物.
主要成果:
- 与稳定患者相比,COPD恶化患者的sCD146血水平显著降低.
- 较低的sCD146水平与较高的COPD严重程度相关 (较高的mMRC,GOLD阶段4,更多的住院治疗,较高的CAT得分).
- sCD146被确定为AECOPD的独立风险因素.
- sCD146,结合临床因素,在识别AECOPD时表现出高准确度 (AUC=0.908).
- 血sCD146与S100A9水平呈负相关性.
结论:
- 在COPD恶化期间,sCD146的血水平下降.
- sCD146可以作为一个有价值的生物标志物来评估COPD严重程度和预测AECOPD.
- 进一步研究sCD146在COPD病原发生中的作用是有必要的.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
81
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
81
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K


